AIM’s Latest Newsletter: The Research Edition, July 2023

Published:  
08/01/2023
Categories:  
Blog - Melanoma360
 | 
Melanoma Research
Image

This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research.

This edition features:

  • Letter from AIM’s President, Sam Guild
  • Notes From the Lab: Novel Targets for Immune Checkpoint Inhibitors
    By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory
  • In Plain English: Neoadjuvant Therapy for Melanoma, and How We Got Here
    By Kim Margolin, M.D., FACP, FASCO
  • Clinical Trials Catch Up: An Interview with Joshua M.V. Mammen, M.D., Ph.D., F.A.C.S.
    By Alicia Rowell, Vice President, AIM at Melanoma

Recent Posts

Featured image for “The Power of Peer Support in Melanoma Survivorship”
Oct. 14, 2025

The Power of Peer Support in Melanoma Survivorship

Featured image for “I’ve Failed First-Line Therapy – Now What?”
Oct. 07, 2025

I’ve Failed First-Line Therapy – Now What?

Featured image for “Caring Through Loss: A Conversation on Bereavement”
Sep. 09, 2025

Caring Through Loss: A Conversation on Bereavement

Featured image for “Advocating for Patients: Letter to the FDA on RP1 Treatment Access”
Sep. 05, 2025

Advocating for Patients: Letter to the FDA on RP1 Treatment Access

Featured image for “Hope on the Horizon: Clinical Trials & Progress in Ocular/Uveal Melanoma”
Sep. 04, 2025

Hope on the Horizon: Clinical Trials & Progress in Ocular/Uveal Melanoma

Filter by Tag